SAB Biotherapeutics (SABS) Interest Coverage Ratio (2021 - 2025)
Historic Interest Coverage Ratio for SAB Biotherapeutics (SABS) over the last 5 years, with Q3 2025 value amounting to 292.87.
- SAB Biotherapeutics' Interest Coverage Ratio fell 10208.45% to 292.87 in Q3 2025 from the same period last year, while for Sep 2025 it was 174.11, marking a year-over-year decrease of 942.46%. This contributed to the annual value of 134.77 for FY2024, which is 1159.58% down from last year.
- According to the latest figures from Q3 2025, SAB Biotherapeutics' Interest Coverage Ratio is 292.87, which was down 10208.45% from 151.25 recorded in Q2 2025.
- In the past 5 years, SAB Biotherapeutics' Interest Coverage Ratio registered a high of 10.82 during Q1 2021, and its lowest value of 292.87 during Q3 2025.
- Moreover, its 5-year median value for Interest Coverage Ratio was 109.56 (2024), whereas its average is 115.96.
- As far as peak fluctuations go, SAB Biotherapeutics' Interest Coverage Ratio plummeted by 96034.54% in 2022, and later skyrocketed by 4172.98% in 2024.
- SAB Biotherapeutics' Interest Coverage Ratio (Quarter) stood at 110.81 in 2021, then rose by 19.12% to 89.62 in 2022, then plummeted by 170.4% to 242.35 in 2023, then skyrocketed by 41.73% to 141.22 in 2024, then crashed by 107.39% to 292.87 in 2025.
- Its Interest Coverage Ratio was 292.87 in Q3 2025, compared to 151.25 in Q2 2025 and 154.85 in Q1 2025.